RankAlpha logo
Back to Rankings

AKTX

Akari TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
AKTX vs peer average
43/100
AKTX vs. peer average (F vs. F)
Grade spread
D 5 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

APRE is the first available peer comparator.

Loose same-sector, similar-market-cap biotech reference; no direct ADC or indication read-through is established.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAPREAprea Therapeutics
AKTX
Akari Therapeutics
APRE
Aprea Therapeutics
Grade
F
D
Momentum
40
10
Value
42
57
Sentiment
17
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs APRE

AKTX / APRE
Grade Position
Below peers
AKTX vs. peer average (F vs. F)
43/100
Momentum
40
AKTX
Value
42
APRE
Sentiment
17
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AKTX
1
APRE
APRE
D
40/100
-1
2
SNGX
SNGX
D
40/100
-1
3
XBIO
XBIO
D
40/100
-1
4
ADIL
Adial Pharmaceuticals Inc Common
F
20/100
Even
5
SNTI
Senti Biosciences Holdings Inc Common
F
20/100
Even
APRE is the first peer returned for this comparison set.